Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of nalbuphine on emergence agitation in children undergoing cochlear implantation
ChiCTR2000040407Phase 4Completed
- Sponsor
- Xijing Hospital
- Start
- Oct 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of nalbuphine in Emergence agitation (EA), sponsored by Xijing Hospital. Started Oct 2020; status: completed.
02
Drugs
nalbuphine
03
Conditions
Emergence agitation (EA)
Beyond the preview
Go deeper on ChiCTR2000040407.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000040407.